
|Articles|June 19, 2017
Clinical Ink and Integron Partner to Streamline IoT-enabled Clinical Trials
Advertisement
Clinical Ink, provider of eSource and patient engagement technologies, and Integron, provider of managed services for the connected health and Internet of Things (IoT) industry, announced a partnership to extent Clinical Ink's capabilites in mobile device and sensor deployment, in order to engage and collect data from patients in clinical trials.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
SCOPE Summit 2026: Where AI Is Making the Most Immediate Impact Across R&D
2
Meeting Halfway: Co-Developing Frameworks for Seamless FSO to FSP Transitions
3
SCOPE Summit 2026: ESG Shifts From Reporting Exercise to Vendor Readiness Test in Clinical Operations
4
Regulatory Uncertainty Emerges Across the Drug Development Lifecycle
5




